January 9th, 2017
Abilify is a popular antipsychotic drug approved by the FDA in 2002 to treat bipolar disorder, major depression, irritability associated with autism and obsessive compulsive disorder. One of the drug’s more controversial side effects includes compulsive gambling in those who take it – even without any prior history of a gambling addiction. This side effect can cause patients to take on severe debt, ruining their lives.
Why Does Gambling Addiction Occur?
Researchers are not completely sure how Abilify works, but they do believe that the drug over stimulates the dopamine reward receptors in the brain, triggering compulsive, high-reward behavior like gambling, binge eating and hypersexual behaviors.
Signs of a gambling addiction include:
- Taking increasingly bigger gambling risks
- Obsession with gambling
- Reliving past gambling experiences
- Using gambling to escape from other emotional problems
- Borrowing money or stealing
- Concealing or lying about gambling
Abilify has been involved in major lawsuits, with plaintiffs claiming that the label does not warn of compulsive sides effects like gambling. As a drug company, the makers of Abilify, Bristol-Myers Squibb, have a responsibility to warn patients of any harmful side effects – otherwise breaching their obligation to the public.
Patients who have experienced a severe gambling addiction after being prescribed Abilify have wreaked havoc on their lives, relationships and finances. Patients who have experienced gambling debt because of Abilify may be able to file lawsuits against Otsuka Pharmaceutical Company, the developer of the drug, and Bristol-Myers Squibb.
Lawsuits against Abilify seek compensation for treatment of compulsive gambling, recovering money lost to gambling and compensation for emotional injuries. If you or a loved one has developed compulsive behaviors after being prescribed Abilify that have caused financial and emotional damage, talk to Arkansas Abilify attorneys to determine if you can file a lawsuit against the drug manufacturers.
November 29th, 2016
Johnson & Johnson first began marketing and selling talcum powder in 1892 to midwives and women who just gave birth. The product quickly grew in popularity, and became an additive in all kinds of toiletry and cosmetic products. Its reach is so great, that even today it is associated with the smell of babies.
For decades, women used the product to dust their genitals and undergarments to deter odor, and the powder was also used in condoms and diaphragms. Beginning in 2009, over a hundred years after the product hit the market, Johnson and Johnson became involved in class-action lawsuits over a connection between talc and ovarian cancer. Lawsuits accuse Johnson and Johnson of negligence, conspiracy and failure to warn of the dangers of the product.
Connection Between Talc and Cancer
Because talc is not an actual medical drug, adequate reports and studies have not been kept or required by the FDA, making it difficult to fully confirm the association between talc and ovarian cancer. In addition, cancer is innately difficult to study, because it’s influenced by many different factors, and it’s ethically unrealistic to expose women to a product that many cause cancer in a study.
However, according to the New York Times, there have been at least 10 small studies that have shown an increased risk of ovarian cancer with the use of talc powder by women long-term around their genitals. And in 2006, the International Agency for Research on Cancer classified talcum powder as a possible carcinogen if used in the female genital area.
Talcum Powder Lawsuits
The first woman to file a lawsuit against Johnson & Johnson was a 49-year-old who developed ovarian cancer after using talcum powder on her genitals everyday for 30 years. That was in 2009 and since then, thousands of additional women with ovarian cancer have filed lawsuits against Johnson & Johnson. In February 2016, two families were awarded multimillion-dollar jury awards with a combined total of $127 million.
If you or a loved one has developed ovarian cancer and believe it might be linked to the use of talcum powder, Arkansas personal injury lawyers can advise you on the next steps to pursue compensation.
July 20th, 2015
Many elderly nursing home patients take medications to prevent blood clots. In fact, reports indicate that one-in-six of the roughly 1.3 million patients living in American nursing homes or long-term care facilities take blood thinners. But what these patients may not realize is that taking these medications may increase the risk of severe bleeding events.
One of the greatest dangers of taking an anticoagulant is the risk of an uncontrollable bleeding event. Pradaxa® and Xarelto® have been linked to these injuries because there’s counteracting drug to stop severe bleeding once it starts. However, even traditional options, such as Coumadin, can present risks to patients.
An estimated 33,000 nursing home patients were hospitalized during a two-year period due to bleeding events associated with Coumadin. An article from NBC Philadelphia News discussed how at least one Arkansas nursing home patient had reported such adverse events associated with the drug.
The drug injury lawyers at Rainwater, Holt & Sexton encourage you to know your legal rights if you’ve been harmed by a prescription drug. Our legal staff is standing by to answer your questions. Give us a call at (800) 767-4815 to discuss your case anytime.
February 23rd, 2015
The drug Risperdal can be an effective treatment for several mental conditions, but it can cause users to suffer serious Risperdal side effects. A study published in the Journal of Clinical Psychopharmacology showed that adolescent and teen males who used the medication were prone to develop gynecomastia—a condition in which a male patient develops an excess growth of breast tissue. The research showed approximately 3 out of 10 users would develop the condition.
Young men aren’t the only ones at risk of developing gynecomastia after taking Risperdal though. Another study published in the journal showed middle-aged men may also face a risk of developing breast tissue after using the medication. Data indicates men between age 45-80 who were taking Risperdal had a 69 percent higher chance of developing gynecomastia than those who did not take the drug.
As a result of these findings, the U.S. Food and Drug Administration has taken action to better protect patients, including considering more stringent warnings on the drug’s packaging and advising doctors to consider prescribing other medications to patients.
The risks associated with Risperdal have prompted the filing of many lawsuits against the makers of the drug. These lawsuits claim Risperdal’s manufacturer and distributor should be held liable for damages for failing to inform patients of the risks the drug posed and for marketing the drug to treat age groups and conditions not yet approved by the FDA. Many of the plaintiffs claim they would not have taken the drug if they knew the risks.
Suffering a drug injury due to another person’s negligence can have a significant impact on an individual’s finances and health. Thats why Rainwater, Holt & Sexton’s team of Little Rock personal injury lawyers are hopeful a decision in the Risperdal cases will bring closure to the victims. We also urge you to seek legal counsel if you were harmed as the result of taking this particular drug.
February 16th, 2015
Soldiers are often required to take medications before deploying to protect them from chemical or biological weapons. However, studies are beginning to link these medications with serious adverse side effects.
One such study has found an association between the genetic makeups of soldiers who took anti-nerve gas pills during Operation Desert Shield and Desert Storm and an increased risk of a drug injury known as Gulf War Illness.
A team of scientists from Baylor University examined the genetic makeups and medical histories of 304 veterans. A total of 144 of those individuals had developed symptoms of Gulf War Illness, while 160 showed no signs of the disease. According to the Military Times, researchers were able to determine if soldiers who developed symptoms of the disease had a genetic variant that the others did not.
Those who developed the disease had a lower active amount of an enzyme known as butyrylcholinesterase in their bodies. The enzyme is capable of breaking down toxic substances in the anti-nerve gas medications veterans were given during service.
The group concluded those who took anti-nerve gas medications and who have lower butyrylcholinesterase counts are more likely to develop Gulf War Illness.
At Rainwater, Holt & Sexton, we know how difficult it can be to overcome drug injuries. That’s why our Little Rock personal injury lawyers encourage all veterans suffering from Gulf War Illness to consider discussing their legal rights with a qualified attorney as soon as possible.
March 24th, 2014
March 24, 2014
Cancer can ravage numerous body parts and systems. While many patients suffering from the disease may benefit from drugs that are used in chemotherapy, new studies are showing those same medications may be causing Drug Injuries that inflict serious harm to the heart.
Experts in the field of cardio oncology have shown that heart disease is the leading cause of death among patients who have battled and beaten cancer. This discovery prompted researchers to look further into the side effects of drugs used to defeat the disease. They found many of the medications used in chemotherapy may be the potential culprits.
According to an article from WNPR News, the risks are only exacerbated in patients who used a combination of chemotherapy drugs and radiation treatments. This information has prompted testing that showed while these options are effective in reducing tumor numbers and sizes, it can also have devastating effects on heart tissue.
While all cancer patients go through a screening process in order to determine cardiac risks prior to beginning treatment, many experts believe the connection between chemotherapy drugs and heart disease need to be further examined.
The Little Rock Personal Injury Lawyers with Rainwater, Holt & Sexton are hopeful a solution to the risks of using such dangerous drugs can be discovered soon!
February 3rd, 2014
February 3, 2014
Numerous products on the market claim they will enhance athletic performance, but many users don’t realize is that these products may be doing more harm than good. The attorneys with Rainwater, Holt & Sexton explain that Workout Supplement Dangers have prompted the U.S. Food and Drug Administration (FDA) to take action by recalling certain products.
According to an FDA Press Release, Mega Slim Herbal Appetite Management pills, manufactured by YoungYou International, are being recalled because they contain the undeclared ingredient, dimethylamylamine (DMAA), a stimulant linked to adverse health conditions, including:
- Elevated Blood Pressure
- Cardiac Arrest
- Heart Attack
- Organ Failure
Anyone in possession of the affected products is instructed to halt use immediately and return the product to the manufacturer for a full refund. Anyone who has been harmed by the product should not only report the incident to the FDA, but Rainwater, Holt & Sexton also encourages injured individuals to discuss their legal options with a qualified attorney immediately. Doing so can help protect victims’ rights to compensation.
December 30th, 2013
December 30, 2013
Errors made by doctors are one of the most common causes of drug injuries. Too often, medical professionals fail to give patients the proper dosage of a medication and reports have also been seen of patients receiving the wrong drug all together. In fact, the Arkansas Drug Injury Lawyers with Rainwater, Holt & Sexton point out statistics showing these errors harm as many as 7,000 patients per year.
These errors leave many citizens concerned as to what actions can be taken to better protect patients from the harm of medication errors. A new study has shown that better communication between patients and medical staff may be an answer to this problem.
According to an article from The Clinical Advisor, researchers examined the cases of 1,255 patient admissions by 84 different physicians. They observed the handoff processes that took place before a patient checked out and determined the rate of medication errors.
The same medical professionals then underwent a two-hour communication training course combined with a discussion on how best to handle patient handoff practices. Following the sessions, researchers recorded a decrease in medication errors that ranged from 18.3 to 33.8 percent.
Rainwater, Holt & Sexton’s team of Arkansas Personal Injury Lawyers recognize the dangers posed by medication errors and hope this most recent research can be implemented in finding ways to reduce the number of drug injuries.
August 5th, 2013
August 5, 2013
For many Americans, workout or dietary supplements are a part of everyday routines. What many do not realize is that some of these products could put them at risk of certain Workout Supplement Dangers.
The U.S Food and Drug Administration (FDA) recently recalled several products manufactured by Purity First Health Products because they contained dangerous ingredients not listed on the packaging. An FDA press release stated the company’s B-50, Multi Mineral, and Vitamin C tablets were each pulled off the market because testing showed they contained the compounds, Methasterone and Dimethazine, both of which are Class III anabolic steroids. Experts say that taking any of these products could result in a user suffering such adverse health events as:
- Increased blood lipid levels
- Increased risk of heart attack or Stroke
- Liver injury
- Muscle pain
- Thyroid dysfunction
People have been instructed to halt the use of these products and dispose of them immediately. If a consumer experiences any health issues associated with the products, they should report the incident to the FDA’s MedWatch program as well. So far, the FDA has received a total of 29 reports from consumers who suffered a side effect from taking the supplements.
The Arkansas Personal Injury Lawyers with Rainwater, Holt & Sexton would also encourage anyone harmed by these products to discuss their legal options with a qualified attorney immediately.
February 20th, 2012
February 20, 2012
Diet pill manufacturer Vivus Inc. is preparing to make a second attempt to persuade the Food and Drug Administration (FDA) to approve one of their products later this week. According to reports from KATV 7 News, FDA officials still have concerns over the safety of the weight-loss medication the company is seeking approval for.
In October 2010, the FDA rejected the company’s proposal for approval of the diet pill Qnexa, saying they needed more information regarding the drug’s safety. Among the risks the FDA was concerned with were potential heart problems and birth defects in the children of women who became pregnant while taking the drug.
Qnexa is a combination of two other drugs that have a long history of complications and abuse potential. One of the main active ingredients in the drug is phentermine, a stimulant that acts as an appetite suppressant and was part of the dangerous fen-phen weight loss combination associated with serious heart complications.
On Wednesday, Vivus will resubmit their proposal by offering to conduct a follow-up study to monitor patients for heart problems after short-term use of the drug.
The Arkansas Drug Injury Lawyers with Rainwater, Holt & Sexton would like to remind you to discuss the risks of taking a medication with your doctor and pharmacist before starting a drug regimen. If you feel it may be unsafe to take a drug, do not hesitate to seek a second opinion from another qualified physician.